GENOSS

Genoss Co., Ltd., founded in South Korea in 2004, is a rapidly expanding medical device manufacturer best known in aesthetics for its dermal filler line. The company combines advanced research—reinvesting over 20% of annual revenue into R&D—with proprietary Hy‑BRID (cross‑linking) technology to produce high-purity, non-animal hyaluronic acid gels with uniform particle size, low BDDE residue, and integrated lidocaine.